Gonzalo Ruiz-de-León

Dr. Gonzalo Ruiz-de-León

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2020 in Toxins
Verified
Journal Article
Open access
PDF file
María-Angeles Serrera-FigalloMaría-Angeles Serrera-Figallo
María-Angeles Serrera-Figallo
Gonzalo Ruiz-de-LeónGonzalo Ruiz-de-León
Gonzalo Ruiz-de-León
Daniel Torres-LagaresDaniel Torres-Lagares
Daniel Torres-Lagares
ACAlejandra Castro-Araya
Alejandra Castro-Araya
OTOmar Torres-Ferrerosa
Omar Torres-Ferrerosa
JGJose-Luis Gutiérrez-Perez
Jose-Luis Gutiérrez-Perez
Introduction: Botulinum neurotoxin (BoNT) is a potent biological toxin and powerful therapeutic tool for a growing number of clinical orofacial applications. BoNT relaxes striated muscle by inhibiting acetylcholine’s release from presynaptic nerve terminals, blocking the neuromuscular junction. It also has an antinociceptive effect on sensory nerve endings, where BoNT and acetylcholine are transported axonally to the central nervous system. In dentistry, controlled clinical trials have demonstrated BoNT’s efficiency in pathologies such as bruxism, facial paralysis, temporomandibular joint (TMJ) disorders, neuropathic pain, sialorrhea, dystonia and more. Aim: This study’s aim was to conduct a systematic literature review to assess the most recent high-level clinical evidence for BoNT’s efficacy and for various protocols (the toxin used, dilution, dosage and infiltration sites) used in several orofacial pathologies. Materials and methods: We systematically searched the MedLine database for research papers published from 2014 to 2019 with randomly allocated studies on humans. The search included the following pathologies: bruxism, dislocation of the TMJ, orofacial dystonia, myofascial pain, salivary gland disease, orofacial spasm, facial paralysis, sialorrhea, Frey syndrome and trigeminal neuralgia. Results: We found 228 articles, of which only 20 met the inclusion criteria: bruxism (four articles), orofacial dystonia (two articles), myofascial pain (one article), salivary gland disease (one article), orofacial spasm (two articles), facial paralysis (three articles), sialorrhea (four articles) or trigeminal neuralgia (three articles). Discussion: The clinical trials assessed showed variations in the dosage, application sites and musculature treated. Thus, applying BoNT can reduce symptoms related to motor muscular activity in the studied pathologies efficiently enough to satisfy patients. We did not identify the onset of any important side effects in the literature reviewed. We conclude that treatment with BoNT seems a safe and effective treatment for the reviewed pathologies.

1 January 2014 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Daniel Torres-LagaresDaniel Torres-Lagares
Daniel Torres-Lagares
CRC. Recio-Lora
C. Recio-Lora
GCG. Castillo-Dali
G. Castillo-Dali
Gonzalo Ruiz-de-LeónGonzalo Ruiz-de-León
Gonzalo Ruiz-de-León
PHP. Hita-Iglesias
P. Hita-Iglesias
JGJose-Luis Gutiérrez-Perez
Jose-Luis Gutiérrez-Perez
Introduction: The aim of this article was to study the influence of anxiety (both state and trait) in postoperative recovery after extraction of third molar together, to establish the role of each of the aspects of anxiety in the results you obtained in an independent and complementary way. Material and Methods: We performed a prospective study of a consecutive series of 88 patients who underwent lower third molar extractions. Before being provided with any information about the operation, patients were asked to complete the Spielberger State-Trait Anxiety Inventory-Trait and State. We have evaluated postoperative swelling and pain, patients completed a 10-point visual analog scale (VAS) at home each day (at approximately the same time of day as the operation) until day 8 after surgery, when the sutures were removed. Results: Regarding postoperative variables between positive and negative trait anxiety groups, consumption of analgesic drugs was higher in positive trait anxiety group in a statistically significant way, while these differences were detected only on specific occasions regarding pain and swelling. Discussion: In the present study, anxiety was taken into account and showed a significant effect in explaining postoperative pain and taking analgesics.

1 January 2014 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
Daniel Torres-LagaresDaniel Torres-Lagares
Daniel Torres-Lagares
MHM. Heras-Meseguer
M. Heras-Meseguer
FAF. Azcarate-Velazquez
F. Azcarate-Velazquez
PHP. Hita-Iglesias
P. Hita-Iglesias
Gonzalo Ruiz-de-LeónGonzalo Ruiz-de-León
Gonzalo Ruiz-de-León
JGJose-Luis Gutiérrez-Perez
Jose-Luis Gutiérrez-Perez
Objectives: To evaluate the effect of informed consent format on preoperative anxiety of patients. Material and Methods: We performed a prospective study (91 patients) undergoing lower third molar extraction. Patients were distributed into three groups. Informed consent for surgery was obtained through a written document, an oral interview or a video recording. Afterwards, patients were asked about their anxiety level and the effect the informed consent had had on it. Results: Whereas the information conveyed both in oral and written formats relieved the patient to some extent (in a scale of -3 to +3) 0.97±1.21 and 0.29±0.97, respectively), the video recording increased patient’s anxiety in a statistically significant way (in a scale of -3 to +3, -0.57±1.43). The difference obtained between the values obtained in oral and written information was not statistically significant. Discussion: The most adequate format, according to our study, would be the oral format.

29 May 2024 in Polymers
Verified
Journal Article
Open access
PDF file
MDMaria Baus Domínguez
Maria Baus Domínguez
EOElena Oliva-Ferrusola
Elena Oliva-Ferrusola
SERAFIN MAZA SOLANOSERAFIN MAZA SOLANO
SERAFIN MAZA SOLANO
Gonzalo Ruiz-de-LeónGonzalo Ruiz-de-León
Gonzalo Ruiz-de-León
María-Angeles Serrera-FigalloMaría-Angeles Serrera-Figallo
María-Angeles Serrera-Figallo
LMLaura Macías-García
Laura Macías-García
Background: Sealing the peri-implant tissue is a determining factor for long-term implant survival. In the transmucosal region, the cervical fraction of the prosthetic crown is in contact with these tissues, so mucointegration will also be influenced by the biomaterial used for the prosthetic restoration. This study aims to compare the tissue response generated by definitive restorative materials and polymeric materials from a histological point of view. Methods: This study performed an observational prospective cohort study in which biopsies of the peri-implant mucosa were taken after placement of implant-supported prosthetic restorations made of different materials (zirconium oxide, lithium disilicate, and PMMA). Results: A statistically significant difference was observed in the increase in the thickness of the non-keratinized epithelium when comparing the definitive materials (zirconium oxide/lithium disilicate) vs. the provisional material (PMMA) and in the number of collagen fibers when comparing zirconium oxide and lithium disilicate. Conclusions: This study found that zirconia is the material that presents the most adequate biological response of peri-implant tissues. It shows a lower intensity of inflammatory cellular content, a total normality in the number of collagen fibers (the arrangement of the fibers is normal in 90% of the cases), and vascular proliferation of connective tissue in 83% of the cases. These parameters make it a material with a predictable response. Similarly, only the following slight statistically significant differences between the definitive and provisional materials are observed, indicating that the biological response generated by the provisional material (PMMA) is not very different from that obtained with the placement of the definitive restoration.

1 December 2015 in Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
Daniel Torres-LagaresDaniel Torres-Lagares
Daniel Torres-Lagares
PHPilar Hita-Iglesias
Pilar Hita-Iglesias
FAFrancisco Azcárate-Velázquez
Francisco Azcárate-Velázquez
RGRoberto Garrido-Serrano
Roberto Garrido-Serrano
Gonzalo Ruiz-de-LeónGonzalo Ruiz-de-León
Gonzalo Ruiz-de-León
JGJose-Luis Gutiérrez-Perez
Jose-Luis Gutiérrez-Perez

13 June 2025 in Gels
Verified
Journal Article
Open access
PDF file
Gonzalo Ruiz-de-LeónGonzalo Ruiz-de-León
Gonzalo Ruiz-de-León
DEDaniela Cortés Eslava
Daniela Cortés Eslava
EHEsther Hernández-Pacheco
Esther Hernández-Pacheco
María-Angeles Serrera-FigalloMaría-Angeles Serrera-Figallo
María-Angeles Serrera-Figallo
Daniel Torres-LagaresDaniel Torres-Lagares
Daniel Torres-Lagares
MDMaria Baus Domínguez
Maria Baus Domínguez
Biopolymer-based dermal fillers have gained attention in facial aesthetics due to their biocompatibility, gel-forming properties, and capacity to stimulate tissue regeneration. However, evidence regarding their clinical performance remains scattered and inconsistent. This systematic review evaluates the current scientific literature on the effectiveness and safety of injectable biopolymers used in facial aesthetic procedures. A systematic search was conducted in PubMed, MEDLINE, and Embase databases for studies published between 2016 and 2024. Only human studies in English assessing clinical efficacy, safety, adverse events, and patient satisfaction were included. Of the 280 articles initially identified, 9 met the inclusion criteria. The selected studies showed improvements in facial volume and wrinkle reduction with gel-based biopolymers such as poly-L-lactic acid (PLLA), polycaprolactone (PCL), and polymethylmethacrylate (PMMA). Most studies reported high patient satisfaction and a low incidence of serious adverse effects. However, methodological heterogeneity and limited long-term data reduced the strength of the evidence. While injectable biopolymers appear to be effective and generally safe, current evidence is limited and variable. Further multicenter randomized trials with standardized protocols and longer follow-up periods are needed. Clinicians should apply these materials with caution, ensuring individualized treatment planning and careful risk assessment.